Oxurion NV/ BE0003846632 /
2024-07-26 5:35:27 PM | Chg. +0.0001 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | High | Low |
---|---|---|---|---|---|---|
0.0002EUR | +100.00% | 19.55 mill. Turnover: 1,812.4650 |
0.0001Bid Size: 65.97 mill. | 0.0002Ask Size: 1.04 bill. | 0.0002 | 0.0001 |
GlobeNewswire
05-23
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-14
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atla...
GlobeNewswire
05-06
Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
GlobeNewswire
04-15
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
GlobeNewswire
04-11
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC
GlobeNewswire
04-10
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully ...
GlobeNewswire
03-27
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atl...
GlobeNewswire
03-26
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atl...
GlobeNewswire
03-21
Information on the Total Number of Voting Rights (Denominator) following Conversion Notices from Atl...